Aptose Biosciences Inc (LTS:0UI8)
C$ 1.33 0 (0%) Market Cap: 10.54 Mil Enterprise Value: 98,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Aptose Biosciences Inc Data Call Transcript

Dec 06, 2020 / 10:00PM GMT
Operator

Greetings. Welcome to Aptose Biosciences Corporate Update Call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Dan Ferry. Thank you. You may begin.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator. Good afternoon. And welcome to the Aptose Biosciences corporate update call in conjunction with the company's participation at the 2020 ASH Annual Meeting. I am Dan Ferry, Investor Relations representative for Aptose Biosciences. Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; Mr. Gregory Chow, Executive Vice President and Chief Financial Officer; Dr. Jotin Marango, Senior Vice President and Chief Business Officer; Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer.

I will now turn the call over to Dr. Rice, Chairman, President and CEO of Aptose Biosciences. Dr. Rice?

William G. Rice
Aptose Biosciences Inc. - Chairman, President & CEO

Thank

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot